NPI: 1336637438 · COLORADO SPRINGS, CO 80920 · Children's Hospital · NPI assigned 04/25/2018
Authorized official MICHAEL, LINDA controls 20+ related entities in our dataset. Read more
| Authorized Official | MICHAEL, LINDA (VP, CHIEF COMPLIANCE OFFICER) |
| NPI Enumeration Date | 04/25/2018 |
Other providers sharing the same authorized official: MICHAEL, LINDA
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 5,068 | $620K |
| 2020 | 11,867 | $905K |
| 2021 | 14,590 | $1.67M |
| 2022 | 24,281 | $4.72M |
| 2023 | 24,478 | $5.51M |
| 2024 | 19,119 | $4.39M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 31,227 | 29,886 | $8.75M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 11,477 | 11,016 | $3.08M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 988 | 963 | $2.65M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4,517 | 4,336 | $1.14M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,319 | 2,157 | $536K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 304 | 292 | $368K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2,376 | 2,301 | $362K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 136 | 132 | $196K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 117 | 113 | $126K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,345 | 3,241 | $120K |
| 42830 | 24 | 24 | $67K | |
| G0378 | Hospital observation service, per hour | 73 | 67 | $61K |
| 95819 | 163 | 163 | $52K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4,743 | 4,095 | $49K |
| 54161 | 12 | 12 | $34K | |
| 95782 | 24 | 24 | $30K | |
| 80053 | Comprehensive metabolic panel | 933 | 840 | $22K |
| J3490 | Unclassified drugs | 10,129 | 4,440 | $21K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 93 | 89 | $18K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 136 | 131 | $15K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 153 | 120 | $11K |
| 96361 | Intravenous infusion, hydration; each additional hour | 17 | 14 | $11K |
| 91300 | 717 | 623 | $10K | |
| 0002A | 393 | 361 | $10K | |
| 87631 | 81 | 80 | $9K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 44 | 44 | $9K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 4,220 | 3,969 | $8K |
| 0001A | 242 | 214 | $6K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,957 | 3,566 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 81 | 80 | $5K |
| 95715 | 12 | 12 | $5K | |
| 81001 | 915 | 862 | $4K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 4,551 | 3,403 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 53 | 51 | $4K |
| J7050 | Infusion, normal saline solution, 250 cc | 107 | 90 | $4K |
| 95700 | 12 | 12 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | 188 | 182 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 44 | 41 | $3K |
| J2704 | Injection, propofol, 10 mg | 3,139 | 2,712 | $2K |
| 91307 | 130 | 130 | $2K | |
| 74240 | 12 | 12 | $2K | |
| 36415 | Collection of venous blood by venipuncture | 669 | 629 | $2K |
| 0071A | 84 | 84 | $2K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,127 | 774 | $1K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 30 | 29 | $1K |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 1,238 | 1,173 | $1K |
| 0072A | 46 | 46 | $1K | |
| 90656 | 30 | 30 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 209 | 201 | $1K |
| J0690 | Injection, cefazolin sodium, 500 mg | 384 | 341 | $781.46 |
| 86140 | 134 | 129 | $743.23 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 14 | 14 | $576.24 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 88 | 85 | $544.19 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 437 | 356 | $323.67 |
| 85046 | 39 | 38 | $270.61 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 30 | 30 | $223.36 |
| 82728 | 17 | 12 | $159.52 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 38 | 37 | $139.46 |
| 83690 | 28 | 24 | $98.48 | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,909 | 1,751 | $79.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 136 | 131 | $66.02 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 37 | 37 | $50.68 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 214 | 165 | $26.72 |
| J8540 | Dexamethasone, oral, 0.25 mg | 145 | 112 | $11.75 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 24 | 24 | $8.58 |
| C1889 | Implantable/insertable device, not otherwise classified | 92 | 87 | $0.00 |